The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden

By Zethraeus N.   Ström O.   Borgström F.   Kanis J.   Jönsson B.  

Osteoporosis International, Vol. 19, Iss. 6, 2008-06 ,pp. : 819-827

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women

By Kanis J.   Borgstrom F.   Johnell O.   Jonsson B.  

Osteoporosis International, Vol. 15, Iss. 11, 2004-11 ,pp. : 862-871

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates

By Earnshaw S. R.   Graham C. N.   Ettinger B.   Amonkar M. M.   Lynch N. O.   Middelhoven H.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2517-2529

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis

By Jönsson B.   Ström O.   Eisman J.   Papaioannou A.   Siris E.   Tosteson A.   Kanis J.  

Osteoporosis International, Vol. 22, Iss. 3, 2011-03 ,pp. : 967-982

Springer Publishing Company

Access to resources Recommend Favorite

Cost‐effectiveness of non‐surgical peri‐implantitis treatments

By  

JOURNAL OF CLINICAL PERIODONTOLOGY, Vol. 42, Iss. 5, 2015-05 ,pp. : 470-477

John Wiley & Sons Inc

Access to resources Recommend Favorite